www.alk.net
  • Your allergy
    • What is allergy
      • House dust mite allergy
      • Pollen allergy
      • Living with allergy
      • Socio-economic impact
    • What is allergic asthma
    • How is allergy diagnosed
    • Treating allergy
  • Our solutions
    • Consumer healthcare
    • Diagnostics
    • Allergy vaccines
      • Production
    • Emergency medicine
  • Our science
    • Scientific focus
    • Science & technology
    • Pipeline
    • Digital innovation
    • Clinical data sharing
    • Collaboration & partnerships
    • Healthcare Professionals
      • Allergy Immunotherapy
      • Reweal
      • Clinical trials
      • Webinars
      • The Henning Lowenstein Research Award
  • Our company
    • Press
    • Our strategy
    • Our leadership
    • Our history
    • Corporate governance
  • Sustainability
  • Investors
    • Overview
    • Financial reporting
      • Risk management
      • Reporting standards
      • Auditors
    • Governance
      • Executive Leadership Team
      • Board of Directors
    • News & Events
      • Company Releases
      • Company releases (DK)
      • Webcasts & presentations
      • Investor calendar
      • Capital Markets Day 2024
    • The Share
      • Dividend history
      • Analyst coverage
      • Analyst estimates
      • Shareholder information
      • Authorizations
    • Contact IR
    • Annual general meeting
      • Annual general meeting (DK)
    • Capital Markets Day 2024
  • Careers
    • Working at ALK
    • Vacant positions
    • Cultural Beliefs
  • Select country
Search

News release

Links: 
Company Releases
Company releases (DK)
Webcasts & presentations
Investor calendar
Capital Markets Day 2024

« Back

ALK — Financial calendar for the 2017 financial year

December 14, 2016

PDF Version

Supporting Materials:
FM_30_16UK_14122016.pdf

 

 

Copenhagen, 2016-12-14 11:12 CET (GLOBE NEWSWIRE) --  

2017 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF):

  • Silent period                                                            10 January 2017
  • Annual report 2016                                                 7 February 2017
  • Annual General Meeting to be held                          15 March 2017
    at ALK                                                                                4.00 p.m.
    Bøge Allé 1
    2970 Hørsholm, Denmark

    Written requests to have specific business
    transacted at the AGM will be included in the
    agenda if received by the company on
    31 January 2017 at the latest
    (may be e-mailed to investor@alk.net)

     
  • Silent period                                                                11 April 2017
  • Three-month interim report (Q1) 2017                          9 May 2017
  • Silent period                                                                19 July 2017
  • Six-month interim report (Q2) 2017                       16 August 2017
  • Silent period                                                         13 October 2017
  • Nine-month interim report (Q3) 2017               10 November 2017
     

  ALK-Abelló A/S

For further information please contact:
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Media: Jeppe Ilkjær, tel. +45 7877 4532, mobile +45 3050 2014

 

  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved